Dallas TX, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that management will participate in the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Wednesday, February 11, 2026 in Snowbird, UT. About Enovis Enovis™ (NYSE: ENOV) is a global medical technology innovator dedicated to improving lives by developing clinically differentiated solutions that enhance patient outcomes an ...

Tornator Grew to a New Level: Group Revenue EUR 232 Million and Balance Sheet EUR 4 Billion – Forest Assets Exceeded 800,000 Hectares Financial Statements release - 3 February 2026 at 3 pm SUMMARY FOR THE PERIOD 1 January – 31 December 2025 ·Turnover increased to EUR 232.2 million (+9.0%). Strong demand raised timber sales prices early in the year, and well-planned timber sales batches met customer needs throughout the year. ·Adjusted operating profit rose again to a new record of EUR 168.4 million (154.1 ...

ISC celebrates 18 consecutive years as one of Saskatchewan’s Top Employers, highlighting its dedication to fostering an exceptional workplace.Key initiatives include supporting employee mental health and well-being through flexible work options, development opportunities and comprehensive employee supports.This recognition reflects ISC’s people-first approach, emphasizing employee well-being, career development and work-life balance. REGINA, Saskatchewan, Feb. 03, 2026 (GLOBE NEWSWIRE) -- For the 18th conse ...

- Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of Ophthalmology (APAO) Congress in Hong Kong on Saturday, 07 February 2026 – - Preclinical data will highlight synergistic antitumor activity for the combination of topotecan and VCN-01 that may improve outcomes in refractory retinoblastoma patients with difficult-to-treat vitreous seeds - ROCKVILLE, Md. and BARCEL ...

MANCHESTER, N.H., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems, today announced that the company has promoted Ian Kent to Senior Vice President, Operations and Jamie Haas to Vice President, Chief Technology Officer. “As we sharpen our focus on executing our long-term strategy, it is critical to backfill key roles within Allegro’s senior leadership team. The ...

SAN JOSE, Calif., Feb. 03, 2026 (GLOBE NEWSWIRE) -- zSpace, Inc. (NASDAQ: ZSPC), a leading provider of augmented and virtual reality (AR/VR) solutions for education, today announced that zSpace Career Explorer™ Powered by Career Coach AI™ has been named a recipient of Tech & Learning’s Best of 2025 Award of Excellence in the Primary Education category. The Tech & Learning Best of Awards recognize educational technology solutions that demonstrate exceptional innovation, usability, and impact in supporting t ...

This is the first trial combining Allarity’s stenoparib with another anti-cancer agent Stenoparib’s favorable safety profile supports potential for use in combination regimens Trial is fully funded by the U.S. Department of Veterans Affairs and is open to enrollment at 11 VA sites throughout the US TARPON SPRINGS, Fla., February 3, 2026 – Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company dedicated to developing stenoparib (2X-121)—a ...

VANCOUVER, British Columbia, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Miata Metals Corp. (CSE: MMET) (FSE: 8NQ) (OTCQX: MMETF) (“Miata” or the “Company”) is pleased to announce that it has completed the first four holes of its fully funded 25,000-metre diamond drilling program at its Sela Creek Gold Project, located in Suriname. The 2026 drill program more than doubles the metres drilled during the Company’s highly successful 2025 campaign and is designed to simultaneously advance the Jon’s Trend gold system towar ...

April 10, 2026 Target Action Date for RP1 in Advanced MelanomaWOBURN, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today announced financial results for the fiscal third quarter ended December 31, 2025 and provided a business update. The Company's Biologics License Application (BLA) resubmission for RP1 (vusolimogene oderparepvec) in anti-PD-1 failed melanoma was accepted b ...

LOS ANGELES, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced its participation in the Janney 6th Annual Bank CEO Forum on Wednesday, February 4, 2026 in Scottsdale, AZ. Bonnie Lee, President and Chief Executive Officer, and Ron Santarosa, Chief Financial Officer, will host one-on-one and small group meetings throughout the day. A copy of the presentation being used for meetings with institutional investo ...